Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)
Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 7, pp. 800-807
Closed Access | Times Cited: 16

Showing 16 citing articles:

Update for: New developments in systemic therapy for advanced biliary tract cancer
Chigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology (2025)
Closed Access
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions
Silvia Camera, Federico Rossari, Silvia Foti, et al.
Targeted Oncology (2025)
Closed Access
Current Status of Targeted Therapy for Biliary Tract Cancer in the Era of Precision Medicine
Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 879-879
Open Access | Times Cited: 3
Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study
Naohiro Okano, Tomonori Mizutani, Shuichi Hironaka
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1726-1727
Closed Access | Times Cited: 1
Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma
Philipp Heumann, Andreas Albert, Karsten Gülow, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1690-1690
Open Access | Times Cited: 1
Integrating Molecular Insights into Biliary Tract Cancer Management: A Review of Personalized Therapeutic Strategies
Mar Ros-Buxó, Ezequiel Mauro, Tamara Saurí, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3615-3629
Open Access | Times Cited: 1
Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies
Christiana Mo, Michelle Sterpi, Hyein Jeon, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2854-2854
Open Access | Times Cited: 1
Phase Ⅱ Study of Combined Sintilimab and Anlotinib with Gemcitabine plus Cisplatin in Advanced Biliary Tract Cancer: Efficacy, Safety and Optimize Dose
Jingjing Li, Shurui Zhou, Xiaoqing Xu, et al.
Research Square (Research Square) (2024)
Closed Access
Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial
Anant Ramaswamy, Prabhat Bhargava, S. Srinivas, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 27, pp. 3218-3227
Closed Access
Reply to N. Okano et al
Anant Ramaswamy, Vikas Ostwal
Journal of Clinical Oncology (2024) Vol. 42, Iss. 14, pp. 1727-1728
Closed Access
Molecular biology of cholangiocarcinoma and its implications for targeted therapy in patient management
Timothy Gilbert, Laura E. Randle, Marc Quinn, et al.
European Journal of Surgical Oncology (2024), pp. 108352-108352
Closed Access
Options in Targeted Therapy for Advanced Cholangiocarcinoma: A 2024 Update
Anca Monica Oprescu Macovei, Dana Paula Venter, Gratiella Georgiana Makkai, et al.
Cureus (2024)
Open Access
Targeted therapies in advanced biliary malignancies: a clinical review
Udhayvir Singh Grewal, Shiva Jashwanth Gaddam, Muhammad Shaalan Beg, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 869-880
Closed Access
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer
Li‐Tzong Chen, A. Vogel, Chih‐Hung Hsu, et al.
ESMO Open (2024) Vol. 9, Iss. 8, pp. 103647-103647
Open Access
New perspectives in biliary tract cancers
Thorsten Oliver Goetze, Christoph Roderburg, Felix W. Friedrich, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 5, pp. 100092-100092
Open Access
Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population
Inwoo Hwang, So Young Kang, Deok Geun Kim, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155806-155806
Open Access
Page 1

Scroll to top